Cargando…

Marked improvement of oral intake with nivolumab monotherapy in a patient with microsatellite instability‐high gastric cancer with insufficient oral intake

Although immune checkpoint inhibitors are commonly less effective for patients with a poor general condition, they can be effective and should be considered for poor general conditions in the case of MSI‐H tumor.

Detalles Bibliográficos
Autores principales: Ogata, Takatsugu, Narita, Yukiya, Misawa, Kazunari, Hosoda, Waki, Muro, Kei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7813093/
https://www.ncbi.nlm.nih.gov/pubmed/33489132
http://dx.doi.org/10.1002/ccr3.3399
_version_ 1783637790279335936
author Ogata, Takatsugu
Narita, Yukiya
Misawa, Kazunari
Hosoda, Waki
Muro, Kei
author_facet Ogata, Takatsugu
Narita, Yukiya
Misawa, Kazunari
Hosoda, Waki
Muro, Kei
author_sort Ogata, Takatsugu
collection PubMed
description Although immune checkpoint inhibitors are commonly less effective for patients with a poor general condition, they can be effective and should be considered for poor general conditions in the case of MSI‐H tumor.
format Online
Article
Text
id pubmed-7813093
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-78130932021-01-22 Marked improvement of oral intake with nivolumab monotherapy in a patient with microsatellite instability‐high gastric cancer with insufficient oral intake Ogata, Takatsugu Narita, Yukiya Misawa, Kazunari Hosoda, Waki Muro, Kei Clin Case Rep Case Reports Although immune checkpoint inhibitors are commonly less effective for patients with a poor general condition, they can be effective and should be considered for poor general conditions in the case of MSI‐H tumor. John Wiley and Sons Inc. 2020-11-18 /pmc/articles/PMC7813093/ /pubmed/33489132 http://dx.doi.org/10.1002/ccr3.3399 Text en © 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Ogata, Takatsugu
Narita, Yukiya
Misawa, Kazunari
Hosoda, Waki
Muro, Kei
Marked improvement of oral intake with nivolumab monotherapy in a patient with microsatellite instability‐high gastric cancer with insufficient oral intake
title Marked improvement of oral intake with nivolumab monotherapy in a patient with microsatellite instability‐high gastric cancer with insufficient oral intake
title_full Marked improvement of oral intake with nivolumab monotherapy in a patient with microsatellite instability‐high gastric cancer with insufficient oral intake
title_fullStr Marked improvement of oral intake with nivolumab monotherapy in a patient with microsatellite instability‐high gastric cancer with insufficient oral intake
title_full_unstemmed Marked improvement of oral intake with nivolumab monotherapy in a patient with microsatellite instability‐high gastric cancer with insufficient oral intake
title_short Marked improvement of oral intake with nivolumab monotherapy in a patient with microsatellite instability‐high gastric cancer with insufficient oral intake
title_sort marked improvement of oral intake with nivolumab monotherapy in a patient with microsatellite instability‐high gastric cancer with insufficient oral intake
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7813093/
https://www.ncbi.nlm.nih.gov/pubmed/33489132
http://dx.doi.org/10.1002/ccr3.3399
work_keys_str_mv AT ogatatakatsugu markedimprovementoforalintakewithnivolumabmonotherapyinapatientwithmicrosatelliteinstabilityhighgastriccancerwithinsufficientoralintake
AT naritayukiya markedimprovementoforalintakewithnivolumabmonotherapyinapatientwithmicrosatelliteinstabilityhighgastriccancerwithinsufficientoralintake
AT misawakazunari markedimprovementoforalintakewithnivolumabmonotherapyinapatientwithmicrosatelliteinstabilityhighgastriccancerwithinsufficientoralintake
AT hosodawaki markedimprovementoforalintakewithnivolumabmonotherapyinapatientwithmicrosatelliteinstabilityhighgastriccancerwithinsufficientoralintake
AT murokei markedimprovementoforalintakewithnivolumabmonotherapyinapatientwithmicrosatelliteinstabilityhighgastriccancerwithinsufficientoralintake